Z51.5
Conditions
Interventions
Group 1: In Subproject 1, the two researcher will visit each of the participating centres for data collection (max. 20 months). During these visits all sedative measures (e.g. medication, dosage, indi
Sponsors
Universitätsklinikum Erlangen, Abteilung für Palliativmedizin, Friedrich-Alexander-Universität Erlangen-Nürnberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: SP1: • Patients who are treated in inpatient and outpatient specialized palliative care, who receive drugs that are potentially suitable for deep continuous sedation and who are at least 18 years old. SP2: • Specialized palliative care (SPC) physicians, nurses and other professionals (from psychology, spiritual care, social work). SPC patients = 18 years and carers with capacity to give informed consent and ability to report on own experiences with sedation (e.g. intermittent sedation) or hypothetical clinical scenarios.
Exclusion criteria
Exclusion criteria: SP1: • Patients who are not treated in inpatient or outpatient specialized palliative care, patients who do not receive drugs that are potentially suitable for deep continuous sedation, patients under the age of 18. SP2: • unable to speak sufficient German, too unwell or too distressed as judged by the clinical team.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SP1: • Description of clinical practice regarding to different types of sedation in specialized palliative care in Germany. SP2: • As this is a qualitative study, there are no endpoints. Aim: To explore healthcare professionals', patients' and carers' experiences and views regarding different types of sedation in SPC and associated challenges. | — |
Secondary
| Measure | Time frame |
|---|---|
| SP1: Objectives: •Description of the treatment practice of palliative sedation in specialized palliative care in Germany in various treatment settings (outpatient/inpatient). SP2: Objectives: • To explore professionals´, patients´ and carers´ experiences and views regarding 1) the understanding of and indications for sedation in SPC; 2) the process of decision making and consent 3) clinical challenges of sedation in SPC (e.g. monitoring, outcomes, i.v. hydration); 4. To contribute to the development of recommendations on good clinical practice of sedation in SPC based on the findings. | — |
Countries
Germany
Contacts
Public ContactViolet;Sandra Handtke;Kurkowski M.Sc.
Klinikum der Universität München, Klinik und Poliklinik für Palliativmedizin, Ludwig-Maximilians-Universität;Universitätsklinikum Erlangen, Abteilung für Palliativmedizin, Friedrich-Alexander-Universität Erlangen-Nürnberg
Outcome results
None listed